Skip to main content

Table 1 Median values with quartiles, except pain distribution as mean (±SD)

From: Cutaneous nociception and neurogenic inflammation evoked by PACAP38 and VIP

 

VIP

PACAP38

Placebo

VASAUC (cm × s)

1.2 (0.6–1.7)*

1.0 (0.4–1.6)*

0.2 (0–0.4)

Pain distribution area (cm2)

5.3 ± 8.0*

2.9 ± 5.3*

1.6 ± 3.5

Peak pain (VAS)

1.3 (0.9–2.8)

1.7 (1.0–2.2)

0.5 (0–1.2)

Pain time (s)

96 (83–136)

63 (49–120)

26 (2–59)

  1. VAS AUC area under VAS-time curve, * P < 0.05 for active drug versus placebo
  2. Placebo values are shown as a mean of placebo on VIP and PACAP38 day
  3. Peak pain and time were not analyzed statistically